DOI QR코드

DOI QR Code

Characteristics of Pneumothorax in a Neonatal Intensive Care Unit

  • Lim, Ho-Seop (Department of Pediatrics, College of Medicine, Soonchunhyang University) ;
  • Kim, Ho (Department of Pediatrics, College of Medicine, Soonchunhyang University) ;
  • Jin, Jang-Yong (Department of Pediatrics, College of Medicine, Soonchunhyang University) ;
  • Shin, Young-Lim (Department of Pediatrics, College of Medicine, Soonchunhyang University) ;
  • Park, Jae-Ock (Department of Pediatrics, College of Medicine, Soonchunhyang University) ;
  • Kim, Chang-Hwi (Department of Pediatrics, College of Medicine, Soonchunhyang University) ;
  • Kim, Sung-Shin (Department of Pediatrics, College of Medicine, Soonchunhyang University)
  • Published : 2011.11.30

Abstract

Purpose: The development of postnatal pneumothorax and its common causes and clinical aspects were studied to promote early diagnosis and proper management. Methods: A retrospective study of neonates who were hospitalized in the neonatal intensive care unit at Soonchunhyang University Bucheon Hospital from 2001 to 2010 was performed. Term neonates were divided into a spontaneous pneumothorax group and a secondary pneumothorax group. The secondary group was divided into term and preterm groups. Results: Of 4,414 inpatients, 57 (1.3%) were diagnosed with pneumothorax. Of term newborn patients, 28 (80%) had a secondary pneumothorax, and seven (20%) had a spontaneous pneumothorax. No differences were observed for gender, birth weight, resuscitation, or duration of admission between the spontaneous and control groups. The duration of treatment with a thoracostomy (20 patients, 57%) was longer in the spontaneous group (5.4${\pm}$2.9 days vs. 2.7${\pm}$2.0 days) than that in the control group. Patients with respiratory distress syndrome (RDS) developed a pneumothorax 22.8 hours after surfactant treatment, whereas patients with transient tachypnea of the newborn (TTN), pneumonia, and meconium aspiration syndrome (MAS) developed pneumothorax after 16.6 hours. Of 50 patients with a secondary pneumothorax, 19 (38%) had RDS, 11 (22%) had MAS, 7 (14%) had TTN, and six (12%) had pneumonia. Among term newborns, 42.9% were treated only with 100% oxygen. Among preterm newborns, 72.6% and 27.3% needed a thoracostomy or ventilator care, respectively. Conclusion: A pneumothorax is likely to develop when pulmonary disease occurs in neonates. Therefore, it is important to carefully identify pneumothorax and provide appropriate treatment.

목적: 신생아기에 기흉 발생과 관련된 호발 요인 및 각 원인에 따른 임상 양상을 조사하여 조기 진단 및 치료 효과 향상을 도모하기 위해 본 연구를 시행하였다. 방법: 2001년부터 2010년까지 순천향대학교 부천병원 신생아 집중치료실에서 기흉으로 진단받은 환아를 대상으로 후향적으로 조사하였다. 만삭아에서 발생한 원발성 기흉군과 이차성 기흉군으로 분류하였고, 이차성 기흉군에서 만삭아군과 미숙아군으로 분류하여 비교 분석하였다. 결과: 총 입원 환자 4,414명 중 57명(1.3%)이 기흉으로 진단받았고 만삭아 이차성 기흉 28명(80%), 만삭아 원발성 기흉 7명(20%)이었다. 두 군간의 성별, 출생 체중, 심폐소생술의 종류, 입원기간에 의미있는 통계학적 차이는 없었다. 흉강 삽관술 시행한 환자(20명, 57%)에서 호전까지의 기간은 원발성 기흉군에서 의미있게 길었다(5.4${\pm}$2.9일 vs. 2.7${\pm}$2.0일). 만삭아 이차성 기흉군에서 신생아 호흡곤란 증후군 선행 환자에서 폐표면활성제 투여 후 22.8시간에 기흉이 발생하였고, 태변 흡입 증후군, 폐렴, 신생아 일과성 빈호흡 환자에서는 16.6시간 후에 기흉이 발생하였다. 이차성 기흉군에서 신생아 호흡곤란 증후군(19명, 38%), 태변 흡입 증후군(11명, 22%), 신생아 일과성 빈호흡(7명, 14%), 폐렴(6명, 12%)이 선행되었다. 이차성 기흉군의 만삭아군에서 환자의 42.9%가 100% 산소 치료만으로 호전되었다. 미숙아군에서는 환자의 72.6%에서 흉강삽관술 및 27.3%에서 인공 기계 환기 치료를 필요로 했다. 결론: 신생아 시기에 폐질환이 존재시 기흉이 호발하였다. 따라서 기흉 속발 여부를 주의 깊게 관찰하고 증상에 맞는 적절한치료가 필요할 것으로 사료된다.

Keywords

References

  1. Posner K, Needleman JP. Pneumothorax. Pediatr Rev 2008;29:69-70. https://doi.org/10.1542/pir.29-2-69
  2. Klinger G, Ish-Hurwitz S, Osovsky M, Sirota L, Linder N. Risk factors for pneumothorax in very low birth weight infants. Pediatr Crit Care Med 2008;9:398-402. https://doi.org/10.1097/PCC.0b013e31816c6e55
  3. Zenciroglu A, Aydemir C, Bas AY, Demirel N. Evaluation of predisposing and prognostic factors in neonatal pneumothorax cases. Tuberk Toraks 2006;54:152-6.
  4. Primhak RA. Factors associated with pulmonary air leak in premature infants receiving mechanical ventilation. J Pediatr 1983;102:764-8. https://doi.org/10.1016/S0022-3476(83)80254-6
  5. Litmanovitz I, Carlo WA. Expectant management of pneumothorax in ventilated neonates. Pediatrics 2008;122:e975-9. https://doi.org/10.1542/peds.2008-1269
  6. Katar S, Devecioglu C, Kervancioglu M, Ulku R. Symptomatic spontaneous pneumothorax in term newborns. Pediatr Surg Int 2006;22:755-8. https://doi.org/10.1007/s00383-006-1740-6
  7. Fanaroff AA, Stoll BJ, Wright LL, Carlo WA, Ehrenkranz RA, Stark AR, et al. Trends in neonatal morbidity and mortality for very low birthweight infants. Am J Obstet Gynecol 2007;196:147. e1-8.
  8. Joo JW, Yang EM, Sohn YJ, Kim MJ, Song ES, Choi YY, et al. Symptomatic spontaneous pneumothorax in the newborn : comorbidities and outcomes. J Korean Soc Neonatol 2008;15:166-71.
  9. Smith J, Schumacher RE, Donn SM, Sarkar S. Clinical course of symptomatic spontaneous pneumothorax in term and late preterm newborns: report from a large cohort. Am J Perinatol 2011;28:163-8. https://doi.org/10.1055/s-0030-1263300
  10. Verma RP, Chandra S, Niwas R, Komaroff E. Risk factors and clinical outcomes of pulmonary interstitial emphysema in extremely low birth weight infants. J Perinatol 2006;26:197-200. https://doi.org/10.1038/sj.jp.7211456
  11. Verder H, Robertson B, Greisen G, Ebbesen F, Albertsen P, Lundstrom K, et al. Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. Danish- Swedish Multicenter Study Group. N Engl J Med 1994;331:1051-5. https://doi.org/10.1056/NEJM199410203311603
  12. Dani C, Bertini G, Pezzati M, Cecchi A, Caviglioli C, Rubaltelli FF. Early extubation and nasal continuous positive airway pressure after surfactant treatment for respiratory distress syndrome among preterm infants <30 weeks' gestation. Pediatrics 2004;113:e560-3. https://doi.org/10.1542/peds.113.6.e560
  13. Escobedo MB, Gunkel JH, Kennedy KA, Shattuck KE, Sanchez PJ, Seidner S, et al. Early surfactant for neonates with mild to moderate respiratory distress syndrome: a multicenter, randomized trial. J Pediatr 2004;144:804-8.
  14. Reininger A, Khalak R, Kendig JW, Ryan RM, Stevens TP, Reubens L, et al. Surfactant administration by transient intubation in infants 29 to 35 weeks' gestation with respiratory distress syndrome decreases the likelihood of later mechanical ventilation: a randomized controlled trial. J Perinatol 2005;25:703-8. https://doi.org/10.1038/sj.jp.7211381
  15. Madansky DL, Lawson EE, Chernick V, Taeusch HW Jr. Pneumothorax and other forms of pulmonary air leak in newborns. Am Rev Respir Dis 1979;120:729-37.
  16. Jung JS, Park SW, Kim CS, Lee SL, Kwon TC. Clinical feature of neonatal pneumothorax induced by respiratory distress syndrome and pneumonia. Korean J Pediatr 2009;52:310-4. https://doi.org/10.3345/kjp.2009.52.3.310
  17. Choi BJ, Jung JW, Bae SC, Park MS, Yang JI. Clinical study of outcome and predisposing factors for spontaneous pneumothorax in the neonates. Korean J Perinatol 2000;11:438-44.
  18. Powers WF, Clemens JD. Prognostic implications of age at detection of air leak in very low birth weight infants requiring ventilatory support. J Pediatr 1993;123:611-7. https://doi.org/10.1016/S0022-3476(05)80964-3
  19. Bashour BN, Balfe JW. Urinary tract anomalies in neonates with spontaneous pneumothorax and/or pneumonediastrnum. Pediatrics 1977;59 Suppl:1048-9.
  20. Al Tawil K, Abu-Ekteish FM, Tamimi O, Al Hathal MM, Al Hathlol K, Abu Laimun B. Symptomatic spontaneous pneumothorax in term newborn infants. Pediatr Pulmonol 2004;37:443-6. https://doi.org/10.1002/ppul.10447
  21. Steinhart JM, Kuhn JP, Eisenberg B, Vaughan RL, Maggioli AJ, Cozza TF. Ultrasound screening of healthy infants for urinary tract abnormalities. Pediatrics 1988;82:609-14.
  22. Mehrabani D, Gowen CW Jr, Kopelman AE. Association of pneumothorax and hypotension with intraventricular haemorrhage. Arch Dis Child 1991;66:48-51. https://doi.org/10.1136/adc.66.1_Spec_No.48
  23. Shin SH, Kim JW, Lee YA, Yoon HS, Lee HJ, Lee KJ. Comparison of therapeutic effects and complications between pigtail catheter and conventional tube thoracotomy for pneumothorax in neonates. J Korean Soc Neonatol 1999;6:24-9.
  24. Esme H, Dogru O, Eren S, Korkmaz M, Solak O. The factors affecting persistent pneumothorax and mortality in neonatal pneumothorax. Turk J Pediatr 2008;50:242-6.
  25. Navaei F, Aliabadi B, Moghtaderi M, Kelishadi R. Predisposing factors, incidence and mortality of pneumothorax in a neonatal intensive care unit in Isfahan, Iran. Zhongguo Dang Dai Er Ke Za Zhi 2010;12:417-20.

Cited by

  1. Pneumothorax in Full-term Neonates Transferred due to Respiratory Distress vol.30, pp.3, 2011, https://doi.org/10.14734/pn.2019.30.3.140